| C02AC02 |
C02AC02 guanfacine |
| C02AC04 |
C02AC04 tolonidine |
| C02AC05 |
C02AC05 moxonidine |
| C02AC06 |
C02AC06 Rilmenidine |
| C02B |
C02B Antiadrenergic Agents, Ganglion-Blocking |
| C02BA |
C02BA Sulfonium Derivatives |
| C02BA01 |
C02BA01 trimetaphan |
| C02BB |
C02BB Secondary And Tertiary Amines |
| C02BB01 |
C02BB01 mecamylamine |
| C02BC |
C02BC Bisquaternary Ammonium Compounds |
| C02C |
C02C Antiadrenergic agents, peripherally acting |
| C02CA |
C02CA Alpha-adrenoreceptor antagonists |
| C02CA01 |
C02CA01 prazosin |
| C02CA02 |
C02CA02 indoramin |
| C02CA03 |
C02CA03 trimazosin |
| C02CA04 |
C02CA04 Doxazosine |
| C02CA06 |
C02CA06 urapidil |
| C02CC |
C02CC Guanidine Derivatives |
| C02CC01 |
C02CC01 betanidine |
| C02CC02 |
C02CC02 guanethidine |
| C02CC03 |
C02CC03 guanoxan |
| C02CC04 |
C02CC04 debrisoquine |
| C02CC05 |
C02CC05 guanoclor |
| C02CC06 |
C02CC06 guanazodine |
| C02CC07 |
C02CC07 guanoxabenz |
| C02D |
C02D Arteriolar smooth muscle, Agents acting on |
| C02DA |
C02DA Thiazide Derivatives |
| C02DA01 |
C02DA01 diazoxide |
| C02DB |
C02DB Hydrazinophthalazine Derivatives |
| C02DB01 |
C02DB01 dihydralazine |